Magnetic resonance tomography (MRT) of intracranial tumours: initial experience with the use of the contrast medium Gadolinium-DTPA.
The present study provides an introduction to the clinical diagnosis of intracranial lesions by means of magnetic resonance tomography (MRT). The demonstration of different tissue qualities (bone and bone marrow, cerebral cortex and medulla, ventricular system (CSF), blood, tumour and perifocal oedema) in the MR tomogram is explained. The principles of specific MRT contrast media and their clinical application in brain tumours are discussed in detail.
D000328:Adult; D000368:Aged; D001254:Astrocytoma / Q000175:diagnosis; D001932:Brain Neoplasms / Q000175:diagnosis*; D002283:Carcinoma, Bronchogenic / Q000556:secondary; D002528:Cerebellar Neoplasms / Q000556:secondary; D003397:Craniopharyngioma / Q000175:diagnosis; D003536:Cystadenocarcinoma / Q000175:diagnosis; D005260:Female; D005682:Gadolinium; D005910:Glioma / Q000175:diagnosis; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008577:Meningeal Neoplasms / Q000175:diagnosis; D008579:Meningioma / Q000175:diagnosis; D008875:Middle Aged; D009464:Neuroma, Acoustic / Q000175:diagnosis; D009959:Oropharyngeal Neoplasms / Q000175:diagnosis; D004369:Pentetic Acid; D010911:Pituitary Neoplasms / Q000175:diagnosis
D004369:Pentetic Acid; D005682:Gadolinium